Recent Articles in the press....

• Lilly Settles Hundres of Zyprexa Lawsuits
• Vioxx Damage Award in Barnett Reduced
• Judge Grants New Trial in Vioxx Case
• FDA Warned Glaxo About Avandia Marketing
• Investor Lawsuit Accuses Glaxo of Misleading on Avandia Risks
• Jury Returns Verdict Against Roche in Accutane Trial
• Some Boston Scientific Claims can Proceed
• FDA plans to put safety warnings on diabetes drugs Avandia and Actos
• $2.6 Million awarded in Accutane suit
• Doctors Want Ban on drug freebies (1/25/06)
• Second Texas Vioxx trial scheduled to start January 24th
• FDA will not release some data on heart devices
• Jury Finds Merck at Fault in Texas Man's Death (Reuters)
• FDA: Guidant Defibrillators will be Recalled
• Lilly to Settle on Zyprexa Label Claims
• FDA: Withdraw Bextra (Birmingham News)
• Painkiller Bextra pulled from market
• Consumer Confusion Persists on Painkillers' Safety
• FDA Panel favors keeping painkillers on the market.
• Merck had early Vioxx warning? (CNN International)
• Vioxx may have caused 140,000 heart attacks
• Bextra Doubles Risk of Heart Attack and Stroke, Study Finds
• Pfizer Warns of Bextra Risks
• Pfizer Finds Health Risk With Celebrex
• FDA stops Crestor ads

• NHTSA Imposes Civil Penalties for Violations

• Welding-related Parkinson's Disease
• Benzene may pose risk in the workplace

• The 20-year HRT drug hype was nothing more than a pharmaceutical industry health scam that suckered most doctors into prescribing useless drugs